NAR Molecular Medicine

Oxford University Press

Journal websitePeer review: Other
Evaluation status available after sign-in

About the journal

NAR Molecular Medicine is an open-access journal published by Oxford University Press in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,300 USD. Declared review time at DOAJ: 10 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Oxford University Press
ISSN
2976-856X
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
2,300 USD
Articles in DOAJ
0
Declared review time
10 weeks
Declared peer-review model
other

Index listings

  • DOAJ · 2025-02-28
Indexing
DOAJ
APC
2,300 USD
Declared review time (DOAJ)
10 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

0

Average review time (journal-declared via DOAJ)

10weeks

Works in OpenAlex

109

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

9

i10-index

6

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2025-02-28
Added to DOAJ
2025-02-28
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
PMC
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
91%
ORCID iDs in current deposits
92%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
9918752080106676
Classification2

Subjects (DOAJ)

Science: Microbiology

LCC codes

QR1-502

Subject areas

  • RNA Research and Splicing
  • RNA and protein synthesis mechanisms
  • RNA and protein synthesis mechanisms
  • RNA Interference and Gene Delivery
  • DNA Repair Mechanisms
  • RNA and protein synthesis mechanisms
  • RNA Research and Splicing
  • DNA and Nucleic Acid Chemistry
Show all subjects (75)
  • RNA Research and Splicing
  • Genetic Neurodegenerative Diseases
  • RNA Interference and Gene Delivery
  • RNA Interference and Gene Delivery
  • RNA modifications and cancer
  • Amyotrophic Lateral Sclerosis Research
  • Genetic Neurodegenerative Diseases
  • Genetic Neurodegenerative Diseases
  • DNA and Nucleic Acid Chemistry
  • RNA modifications and cancer
  • DNA and Nucleic Acid Chemistry
  • Epigenetics and DNA Methylation
  • RNA regulation and disease
  • CRISPR and Genetic Engineering
  • Mitochondrial Function and Pathology
  • Mitochondrial Function and Pathology
  • Genomics and Rare Diseases
  • Reproductive Biology and Fertility
  • SARS-CoV-2 and COVID-19 Research
  • DNA Repair Mechanisms
  • Advanced biosensing and bioanalysis techniques
  • Genomics and Chromatin Dynamics
  • DNA Repair Mechanisms
  • Advanced biosensing and bioanalysis techniques
  • Genetics and Neurodevelopmental Disorders
  • CRISPR and Genetic Engineering
  • CRISPR and Genetic Engineering
  • Muscle Physiology and Disorders
  • Genomics and Phylogenetic Studies
  • Genetics and Neurodevelopmental Disorders
  • Epigenetics and DNA Methylation
  • Epigenetics and DNA Methylation
  • Amyotrophic Lateral Sclerosis Research
  • Bacteriophages and microbial interactions
  • Bacteriophages and microbial interactions
  • Mosquito-borne diseases and control
  • Amyotrophic Lateral Sclerosis Research
  • Alzheimer's disease research and treatments
  • Genetics and Neurodevelopmental Disorders
  • Mitochondrial Function and Pathology
  • Bacterial Genetics and Biotechnology
  • Tuberculosis Research and Epidemiology
  • Reproductive Biology and Fertility
  • Ubiquitin and proteasome pathways
  • Molecular Biology Techniques and Applications
  • RNA regulation and disease
  • Plant Virus Research Studies
  • Chromosomal and Genetic Variations
  • Reproductive Biology and Fertility
  • Tuberculosis Research and Epidemiology
  • Ubiquitin and proteasome pathways
  • Virus-based gene therapy research
  • RNA regulation and disease
  • Molecular Biology Techniques and Applications
  • Single-cell and spatial transcriptomics
  • Virus-based gene therapy research
  • Bacterial Genetics and Biotechnology
  • interferon and immune responses
  • Plant Virus Research Studies
  • Developmental Biology and Gene Regulation
  • Virus-based gene therapy research
  • Mosquito-borne diseases and control
  • HIV Research and Treatment
  • Muscle Physiology and Disorders
  • HIV Research and Treatment
  • Mosquito-borne diseases and control
  • Muscle Physiology and Disorders

Keywords (DOAJ)

  • nucleic acids
  • dna and rna therapeutics
  • molecular medicine
  • virology
  • molecular and structural biology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: